The involvement of α 2A-adrenoceptors in morphine analgesia, tolerance and withdrawal in mice

European Journal of Pharmacology

Volumn 497, Issue 2, 2004, Pages 161-171

  Üzdoǧan, Ü Kazim ^a   Lähdesmäki, Janne ^a   Hakala, Kristo ^a   Scheinin, Mika ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

2 Adrenoceptor agonist; 2A Adrenoceptor; Analgesia; Morphine tolerance; Morphine withdrawal; Prazosin

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DEXMEDETOMIDINE; MORPHINE; NALOXONE; PRAZOSIN;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG TOLERANCE; DRUG WITHDRAWAL; GENOTYPE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST; WEIGHT REDUCTION; WILD TYPE;

ANALGESICS, OPIOID; ANIMALS; DRUG TOLERANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; RECEPTORS, ADRENERGIC, ALPHA-2; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 4143124564     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.06.051     Document Type: Article

References (76)

1. J. Airio, and L. Ahtee The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment Br. J. Pharmacol. 126 1999 1609 1619
2. K.O. Aley, and J.D. Levine Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal J. Neurosci. 17 1997 735 744
3. J.D. Altman, A.U. Trendelenburg, L. MacMillan, D. Bernstein, L. Limbird, K. Starke, B.K. Kobilka, and L. Hein Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice Mol. Pharmacol. 56 1999 154 161
4. T. Antonelli, M. Morari, A. Magri, and C. Bianchi Effect of alpha-adrenoreceptors in the control of spontaneous motility and morphine withdrawal syndrome Boll. Soc. Ital. Biol. Sper. 67 1991 965 971
5. G. Aston-Jones, J.M. Delfs, J. Druhan, and Y. Zhu The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal Ann. N. Y. Acad. Sci. 877 1999 486 498
6. G.A. Bentley, S.H. Newton, and J. Starr Studies on the antinociceptive action of alpha-agonist drugs and their interactions with opioid mechanisms Br. J. Pharmacol. 79 1983 125 134
7. N. Bhana, K.L. Goa, and K.J. McClellan Dexmedetomidine Drugs 59 2000 263 268
8. C. Blanchet, and C. Luscher Desensitization of mu-opioid receptors-evoked potassium currents: initiation at the receptor, expression at the effector Proc. Natl. Acad. Sci. U. S. A. 99 2002 4674 4679
9. L.M. Bohn, R.R. Gainetdinov, F.T. Lin, R.J. Lefkowitz, and M.G. Caron Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence Nature 408 2000 720 723
10. L.M. Bohn, F. Xu, R.R. Gainetdinov, and M.G. Caron Potentiated opioid analgesia in norepinephrine transporter knock-out mice J. Neurosci. 20 2000 9040 9045
11. L.M. Bohn, R.J. Lefkowitz, and M.G. Caron Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice J. Neurosci. 22 2002 10494 10500
12. P. Bousquet Imidazoline receptors Neurochem. Int. 30 1997 3 7
13. S. Browning, D. Lawrence, A. Livingston, and B. Morris Interactions of drugs active at opiate receptors and drugs active at alpha 2-receptors on various test systems Br. J. Pharmacol. 77 1982 487 491
14. B. Chieng, and M.D. Christie Local opioid withdrawal in rat single periaqueductal gray neurons in vitro J. Neurosci. 16 1996 7128 7136
15. Y.M. Dambisya, C.L. Wong, and K. Chan Effects of sympathomimetic agents on opiate analgesia, tolerance and dependence in mice Methods Find. Exp. Clin. Pharmacol. 13 1991 239 248
16. F.E. D'Amour, and D.L. Smith A method of determining loss of pain sensation J. Pharmacol. Exp. Ther. 72 1941 74 79
17. J.M. Delfs, Y. Zhu, J.P. Druhan, and G. Aston-Jones Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion Nature 403 2000 430 434
18. P. Devoto, G. Flore, L. Pira, M. Diana, and G.L. Gessa Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal Psychopharmacology 160 2002 220 224
19. A.O. El-Kadi, and S.I. Sharif The influence of chronic treatment with clonidine, yohimbine and idazoxan on morphine withdrawal Psychopharmacology (Berl.) 132 1997 67 73
20. C.A. Fairbanks, and G.L. Wilcox Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine J. Pharmacol. Exp. Ther. 288 1999 1107 1116
21. J.A. Fuentealba, M.I. Forray, and K. Gysling Chronic morphine treatment and withdrawal increase extracellular levels of norepinephrine in the rat bed nucleus of the stria terminalis J. Neurochem. 75 2000 741 748
22. R.W. Gear, and J.D. Levine Antinociception produced by an ascending spino-supraspinal pathway J. Neurosci. 15 1995 3154 3161
23. L.R. Gowing, M. Farrell, R.L. Ali, and J.M. White Alpha2-adrenergic agonists in opioid withdrawal Addiction 97 2002 49 58
24. T.Z. Guo, J. Tinklenberg, R. Oliker, and M. Maze Central alpha 1-adrenoceptor stimulation functionally antagonizes the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist Anesthesiology 75 1991 252 256
25. M. Hascoet, M. Bourin, and J. Bradwejn Behavioral models in mice. Implication of the alpha noradrenergic system Prog. Neuro-psychopharmacol. Biol. Psychiatry 15 1991 825 840
26. Y. Hayashi, T.Z. Guo, and M. Maze Hypnotic and analgesic effects of the alpha 2-adrenergic agonist dexmedetomidine in morphine-tolerant rats Anesth. Analg. 83 1996 606 610
27. G. Hedo, and J.A. Lopez-Garcia Alpha-1A adrenoceptors modulate potentiation of spinal nociceptive pathways in the rat spinal cord in vitro Neuropharmacology 41 2001 862 869
28. J.C. Hunter, D.J. Fontana, L.R. Hedley, J.R. Jasper, R. Lewis, R.E. Link, R. Secchi, J. Sutton, and R.M. Eglen Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice Br. J. Pharmacol. 122 1997 1339 1344
29. J.L. Hylden, D.A. Thomas, M.J. Iadarola, R.L. Nahin, and R. Dubner Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms Eur. J. Pharmacol. 194 1991 135 143
30. J.J. Idänpään-Heikkilä, P. Rauhala, and P.T. Männistö Neuroendocrine effects of dexmedetomidine: evidence of cross-tolerance between a mu-opioid agonist and an alpha 2-adrenoceptor agonist in growth hormone secretion of the male rat Pharmacol. Toxicol. 78 1996 136 142
31. V. Iglesias, L.F. Alguacil, C. Alamo, and E. Cuenca Effects of yohimbine on morphine analgesia and physical dependence in the rat Eur. J. Pharmacol. 211 1992 35 38
32. E.A. Kalso, A.F. Sullivan, H.J. McQuay, A.H. Dickenson, and B.P. Roques Cross-tolerance between mu opioid and alpha-2 adrenergic receptors, but not between mu and delta opioid receptors in the spinal cord of the rat J. Pharmacol. Exp. Ther. 265 1993 551 558
33. B.L. Kieffer, and C. Gaveriaux-Ruff Exploring the opioid system by gene knockout Prog. Neurobiol. 66 2002 285 306
34. J. Lähdesmäki, J. Sallinen, E. MacDonald, B.K. Kobilka, V. Fagerholm, and M. Scheinin Behavioral and neurochemical characterization of alpha(2A)-adrenergic receptor knockout mice Neuroscience 113 2002 289 299
35. J. Lähdesmäki, J. Sallinen, E. MacDonald, J. Sirviö, and M. Scheinin Alpha2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the alpha2A-adrenoceptor subtype Neuropharmacology 44 2003 882 892
36. J. Lähdesmäki, M. Scheinin, A. Pertovaara, and H. Mansikka The alpha2A-adrenoceptor subtype is not involved in inflammatory hyperalgesia or morphine-induced antinociception Eur. J. Pharmacol. 468 2003 183 189
37. P.P. Lakhlani, L.B. MacMillan, T.Z. Guo, B.A. McCool, D.M. Lovinger, M. Maze, and L.E. Limbird Substitution of a mutant alpha2a-adrenergic receptor via hit and run gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo Proc. Natl. Acad. Sci. U. S. A. 94 1997 9950 9955
38. X. Li, and J.C. Eisenach Alpha2A-adrenoceptor stimulation reduces capsaicin-induced glutamate release from spinal cord synaptosomes J. Pharmacol. Exp. Ther. 299 2001 939 944
39. J.G. Liu, and K.J. Anand Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence Brain. Res. Brain. Res. Rev. 38 2001 1 19
40. R.H. Liu, and Z.Q. Zhao Selective blockade by yohimbine of descending spinal inhibition from lateral reticular nucleus but not from locus coeruleus in rats Neurosci. Lett. 142 1992 65 68
41. E. MacDonald, H. Scheinin, and M. Scheinin Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative Eur. J. Pharmacol. 158 1988 119 127
42. R. Maldonado Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence Neurosci. Biobehav. Rev. 21 1997 91 104
43. A.B. Malmberg, L.R. Hedley, J.R. Jasper, J.C. Hunter, and A.I. Basbaum Contribution of alpha(2) receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine Br. J. Pharmacol. 132 2001 1827 1836
44. M.J. Millan Descending control of pain Prog. Neurobiol. 66 2002 355 474
45. M.J. Millan, A. Dekeyne, A. Newman-Tancredi, D. Cussac, V. Audinot, G. Milligan, D. Duqueyroix, S. Girardon, J. Mullot, J.A. Boutin, J.P. Nicolas, A. Renouard-Try, J.M. Lacoste, and A. Cordi S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine J. Pharmacol. Exp. Ther. 295 2000 1192 1205
46. H.F. Miranda, F. Sierralta, and G. Pinardi An isobolographic analysis of the adrenergic modulation of diclofenac antinociception Anesth. Analg. 93 2001 430 435
47. I. Mitrovic, M. Margeta-Mitrovic, S. Bader, M. Stoffel, L.Y. Jan, and A.I. Basbaum Contribution of GIRK2-mediated postsynaptic signaling to opiate and alpha 2-adrenergic analgesia and analgesic sex differences Proc. Natl. Acad. Sci. U. S. A. 100 2003 271 276
48. E.J. Nestler, and K. Aghajanian Molecular and cellular basis of addiction Science 278 1997 58 63
49. E.J. Nestler, M.T. Berhow, and E.S. Brodkin Molecular mechanisms of drug addiction: adaptations in signal transduction pathways Mol. Psychiatry. 1 1996 190 199
50. M.H. Ossipov, L.J. Suarez, and T.C. Spaulding Antinociceptive interactions between alpha 2-adrenergic and opiate agonists at the spinal level in rodents Anesth. Analg. 68 1989 194 200
51. M.H. Ossipov, S. Harris, P. Lloyd, and E. Messineo An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates J. Pharmacol. Exp. Ther. 255 1990 1107 1116
52. M.H. Ossipov, R. Lozito, E. Messineo, J. Green, S. Harris, and P. Lloyd Spinal antinociceptive synergy between clonidine and morphine, U69593, and DPDPE: isobolographic analysis Life Sci. 47 1990 PL71 PL76
53. U.K. Özdoǧan, J. Lähdesmäki, and M. Scheinin Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice Eur. J. Pharmacol. 460 2003 127 134
54. G. Paalzow Development of tolerance to the analgesic effect of clonidine in rats. Cross-tolerance to morphine Naunyn-Schmiedeberg's Arch. Pharmacol. 304 1978 1 4
55. A. Parini, C.G. Moudanos, N. Pizzinat, and S.M. Lanier The elusive family of imidazoline binding sites Trends Pharmacol. Sci. 17 1996 13 16
56. A. Pinelli, and S. Trivulzio Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine J. Pharmacol. Toxicol. Methods 38 1997 117 131
57. T. Reisine, and G. Pasternak Opioid analgesics and antagonists A.G. Gilman J.G. Hardman L.E. Limbird Goodman and Gilman's The Pharmacological Basis of Therapeutics 9th ed. 1996 McGraw-Hill New York 521 555
58. L.E. Robson, R.F. Mucha, and H.W. Kosterlitz The role of interaction between opiate receptors and alpha-adrenergic receptors in tolerance and dependence Biochem. Soc. Trans. 11 1983 64 65
59. S.C. Roerig Decreased spinal morphine/clonidine antinociceptive synergism in morphine-tolerant mice Life Sci. 56 1995 L115 L122
60. S.C. Roerig, S. Lei, K. Kitto, J.K. Hylden, and G.L. Wilcox Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors J. Pharmacol. Exp. Ther. 262 1992 365 374
61. J. Sawynok, and A. Reid Noradrenergic mediation of spinal antinociception by 5-hydroxytryptamine: characterization of receptor subtypes Eur. J. Pharmacol. 223 1992 49 56
62. J. Scheibner, A.U. Trendelenburg, L. Hein, K. Starke, and C. Blandizzi Alpha 2-adrenoceptors in the enteric nervous system: a study in alpha 2A-adrenoceptor-deficient mice Br. J. Pharmacol. 135 2002 697 704
63. B. Scheinin, L. Lindgren, T. Randell, H. Scheinin, and M. Scheinin Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and perioperative fentanyl Br. J. Anaesth. 68 1992 126 131
64. S. Schreiber, V. Getslev, A. Weizman, and C.G. Pick The antinociceptive effect of moclobemide in mice is mediated noradrenergic pathways Neurosci. Lett. 253 1998 183 186
65. S. Schreiber, M.M. Backer, and C.G. Pick The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms Neurosci. Lett. 273 1999 85 88
66. S.I. Sharif, and A.O. El-Kadi Modification of naloxone-precipitated withdrawal symptoms in mice by drugs acting on alpha(2)-adrenoceptors Behav. Pharmacol. 4 1996 334 340
67. F. Sierralta, D. Naquira, G. Pinardi, and H.F. Miranda Alpha-adrenoceptor and opioid receptor modulation of clonidine-induced antinociception Br. J. Pharmacol. 119 1996 551 554
68. L.S. Stone, L.B. MacMillan, K.F. Kitto, L.E. Limbird, and G.L. Wilcox The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy J. Neurosci. 17 1997 7157 7165
69. A.F. Sullivan, E.A. Kalso, H.J. McQuay, and A.H. Dickenson Evidence for the involvement of the mu but not delta opioid receptor subtype in the synergistic interaction between opioid and alpha 2 adrenergic antinociception in the rat spinal cord Neurosci. Lett. 139 1992 65 68
70. D.A. Taylor, and W.W. Fleming Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids J. Pharmacol. Exp. Ther. 297 2001 11 18
71. P.I. Tsao, and M. von Zastrow Diversity and specificity in the regulated endocytic membrane trafficking of G- protein-coupled receptors Pharmacol. Ther. 89 2001 139 147
72. T.D. Ware, and D. Paul Cross-tolerance between analgesia produced by xylazine and selective opioid receptor subtype treatments Eur. J. Pharmacol. 389 2000 181 185
73. E.L. Way, H.H. Loh, and F.H. Shen Simultaneous quantitative assessment of morphine tolerance and physical dependence J. Pharmacol. Exp. Ther. 167 1969 1 8
74. K.P. Zeitz, A.B. Malmberg, H. Gilbert, and A.I. Basbaum Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice Pain 94 2001 245 253
75. D. Zelena, D.T. Kiem, I. Barna, and G.B. Makara Alpha 2-adrenoreceptor subtypes regulate ACTH and beta-endorphin secretions during stress in the rat Psychoneuroendocrinology 24 1999 333 343
76. H. Zhong, and K.P. Minneman Alpha1-adrenoceptor subtypes Eur. J. Pharmacol. 375 1999 261 276